Fonte: Acta Neuropathologica. Unidade: FMRP
Assuntos: NEOPLASIAS CEREBRAIS, GLIOMA, GENES, FUSÃO CELULAR, METILAÇÃO DE DNA, ONCOGENES, PROTEÍNAS PROTO-ONCOGÊNICAS
ABNT
WEFERS, Annika K. et al. Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course. Acta Neuropathologica, v. 139, n. 1, p. 193-209, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00401-019-02078-w. Acesso em: 31 out. 2024.APA
Wefers, A. K., Stichel, D., Schrimpf, D., Coras, R., Pages, M., Tauziède-Espariat, A., et al. (2020). Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course. Acta Neuropathologica, 139( 1), 193-209. doi:10.1007/s00401-019-02078-wNLM
Wefers AK, Stichel D, Schrimpf D, Coras R, Pages M, Tauziède-Espariat A, Varlet P, Schwarz D, Oliveira RS de, Queiroz RG de P, Valera ET. Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course [Internet]. Acta Neuropathologica. 2020 ; 139( 1): 193-209.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s00401-019-02078-wVancouver
Wefers AK, Stichel D, Schrimpf D, Coras R, Pages M, Tauziède-Espariat A, Varlet P, Schwarz D, Oliveira RS de, Queiroz RG de P, Valera ET. Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course [Internet]. Acta Neuropathologica. 2020 ; 139( 1): 193-209.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s00401-019-02078-w